Investigating cancer health disparities in Black women in Chicago.
The Northwestern University Cancer Health Equity Research SPORE (NU-CHERS)
This study is looking at how endometrial and ovarian cancers affect Black women in Chicago, aiming to work together with the community to find out why there are differences in treatment and survival, so we can improve care and support for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10488603 on NIH RePORTER |
What this research studies
This research focuses on understanding and addressing the disparities in gynecologic cancers, particularly endometrial and ovarian cancers, among Black women in Chicago. It aims to establish a collaborative infrastructure that combines academic and community efforts to generate scientific findings. The research includes analyzing tumor genomics and DNA methylation differences to uncover biological factors that may influence treatment responses and survival rates. By leveraging the resources of Northwestern University and its cancer center, the project seeks to create a comprehensive approach to cancer health equity.
Who could benefit from this research
Good fit: Ideal candidates for this research are Black women diagnosed with endometrial or ovarian cancers.
Not a fit: Patients who do not identify as Black or those without a diagnosis of endometrial or ovarian cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and outcomes for Black women facing gynecologic cancers.
How similar studies have performed: Previous research has shown success in addressing health disparities through community-based approaches, making this initiative a promising continuation of those efforts.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Simon, Melissa a. — Northwestern University at Chicago
- Study coordinator: Simon, Melissa a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.